Abstract
H–2 gene transfection was used to restore expression of H–2K antigens in metastatic and non-metastatic subclones of a murine fibrosarcoma that lack their major histocompatibility complex-encoded H–2K antigens. De novo expression of H–2K reduced tumorigenicity and abolished the formation of metastasis in syngeneic mice. Expression of H–2K may lead to effective recognition of the disseminating tumour cells by the host immune system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zinkernagel, R. M. & Doherty, P. C. Adv. Immun. 27, 51–177 (1979).
Isakov, N., Katzav, S., Feldman, M. & Segal, S. J. natn. Cancer Inst. 71, 139–145 (1983).
Eisenbach, L., Segal, S. & Feldman, M. Int. J. Cancer 32, 113–120 (1983).
De Baetselier, P., Katzav, S., Gorelik, E., Feldman, M. & Segal, S. Nature 288, 179–181 (1980).
Katzav, S., De Baetselier, P., Gorelik, E., Feldman, M. & Segal, S. Transplant Proc. 13, 742–746 (1981).
Katzav, S., De Baetselier, P., Tartakovsky, B., Feldman, M. & Segal, S. J. natn. Cancer Inst. 71, 317–324 (1983).
Katzav, S. et al. Transplant Proc. 15, 162–170 (1983).
Katzav, S., Segal, S. & Feldman, M. Int. J. Cancer 33, 407–415 (1984).
Katzav, S. S. & Feldman, M. J. natn. Cancer Inst. (in the press).
Mellor, A. L. et al. Nature 298, 529–534 (1982).
Arnold, B., Burgert, H.-G., Archibald, A. L. & Kvist, S. Nucleic Acids Res. 12, 9473–9487 (1984).
Colbere-Garapin, F., Horodniceanu, F., Kourilsky, P. & Garapin, A.-C. J. molec. Biol. 150, 1–14 (1981).
Hämmerling, G. J., Rüsch, E., Tada, N., Kimura, S. & Hämmerling, U. Proc. natn. Acad. Sci. U.S.A. 79, 4737–4741 (1982).
Wernet, D. & Lilly, F. J. exp. Med. 144, 266–271 (1976).
Wernet, D., Shafran, H. & Lilly, F. J. exp. Med. 144, 654–661 (1976).
Miller, S. D., Sy, M. S. & Claman, H. N. J. exp. Med. 147, 788–799 (1978).
Hasek, M. & Chutna, J. Immun. Rev. 46, 3–26 (1979).
Holtkamp, B., Fischer-Lindahl, K., Segal, M. & Rajewsky, K. Immunogenetics 9, 405–421 (1979).
Schmidt, W., Atfield, G. & Festenstein, H. Immunogenetics 8, 311–321 (1979).
Schmidt, W. & Festenstein, H. Immunogenetics 16, 247–264 (1982).
Bernards, R., Schrier, P. I., Houweling, A., Bos, J. L. & van der Eb, A. J. Nature 305, 776–779 (1983).
Eisenbach, L. et al. Int. J. Cancer 34, 567 (1984).
Hui, K., Grosveld, F. & Festenstein, H. Nature 311, 750–752 (1984).
Sanderson, A. R. & Beverly, P. C. L. Immun. Today 4, No. 8 211–213 (1983).
Natali, P. G. et al. Cancer Res. 43, 660–668 (1983).
Wigler, M. et al. Proc. natn. Acad. Sci. U.S.A. 76, 1373–1376 (1979).
Lemke, H., Hämmerling, G. J., Höhmann, C. & Rajewsky, K. Nature 271, 249–251 (1978).
Lemke, H., Hämmerling, G. J. & Hämmerling, U. Immun. Rev. 47, 175–206 (1979).
Gorelik, E. et al. Cancer Metastasis Rev. 1, 83–94 (1982).
O'Farrell, P. H. J. biol. Chem. 250, 4007–4012 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wallich, R., Bulbuc, N., Hämmerling, G. et al. Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfection. Nature 315, 301–305 (1985). https://doi.org/10.1038/315301a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/315301a0
This article is cited by
-
MHC heterogeneity and response of metastases to immunotherapy
Cancer and Metastasis Reviews (2021)
-
Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition
Cancer Gene Therapy (2014)
-
Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions
BMC Gastroenterology (2013)
-
Clinical impact of HLA class I expression in rectal cancer
Cancer Immunology, Immunotherapy (2008)
-
Gene therapy for carcinoma of the breast
Cancer Gene Therapy (2006)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.